Product Images Cenestin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Cenestin NDC 54868-5415 by Physicians Total Care, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Cenestin® 1.25 mg Packaging Label - 1432
structural formulae Sodium Estrone Sulfate - 410f9433 98ed 4c3f abb1 2386296d2f72 01
structural formulae Sodium 17α-Dihydroequilin Sulfate - 410f9433 98ed 4c3f abb1 2386296d2f72 02
structural formulae Sodium 17α-Estradiol Sulfate - 410f9433 98ed 4c3f abb1 2386296d2f72 03
structural formulae Sodium Equilenin Sulfate - 410f9433 98ed 4c3f abb1 2386296d2f72 04
structural formulae Sodium 17β-Dihydroequilenin Sulfate - 410f9433 98ed 4c3f abb1 2386296d2f72 05
structural formulae Sodium Equilin Sulfate - 410f9433 98ed 4c3f abb1 2386296d2f72 06
structural formulae Sodium 17β-Dihydroequilin Sulfate - 410f9433 98ed 4c3f abb1 2386296d2f72 07
structural formulae Sodium 17β-Estradiol Sulfate - 410f9433 98ed 4c3f abb1 2386296d2f72 08
structural formulae Sodium 17α-Dihydroequilenin Sulfate - 410f9433 98ed 4c3f abb1 2386296d2f72 09
Figure 1: Graph of Mean Plasma Concentration of Unconjugated Estrogens After a 2 x 0.625 mg Cenestin Dose Under Fasting Conditions - 410f9433 98ed 4c3f abb1 2386296d2f72 10
This is a graph labeled "Figure 1" that shows the mean plasma concentration of unconjugated estrogens after a 2 x 0.625 mg Cenestin dose under fasting conditions. The graph shows the plasma concentration in pg/mL on the y-axis and time from dosing on the x-axis. The graph also includes two lines representing different estrogens and a baseline.*
Figure 2: Graphical Summary of % Superficial Cells Results in Patients Following 16 Weeks of Treatment with Cenestin 0.3mg Mean +/- SE - 410f9433 98ed 4c3f abb1 2386296d2f72 11
The text describes a figure titled "Summary of % Superficial Cells Results in Patients Following 16 Weeks of Treatment with Cenestin 0.3 mg". The figure presents the mean and standard error data for the percentage of superficial cells in patients after 16 weeks of treatment with Cenestin 0.3 mg at various weeks of treatment.*
Cenestin® 0.625 mg Packaging Label - 4879
Cenestin® 0.45 mg Packaging Label - 5415
This is an advertisement for a medication called "Cenestin" in the form of tablets, with a concentration of 0.45M6. The advertisement appears to be targeting physicians or healthcare professionals, and may be related to total care. No further information is available from this text.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.